These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8689981)

  • 1. Quality of intravenous infusion fluids manufactured in Kenya.
    Aluoch-Orwa JA; Ondari CO; Kibwage IO; Hoogmartens J
    East Afr Med J; 1995 Dec; 72(12):800-4. PubMed ID: 8689981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two methods for detecting microbial contamination in intravenous fluids.
    Posey LM; Nutt RE; Thomson PD
    Am J Hosp Pharm; 1981 May; 38(5):659-62. PubMed ID: 6792910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventitious contamination of intravenous admixtures during sterility testing.
    Bernick JJ; Brown DG; Bell JE
    Am J Hosp Pharm; 1979 Nov; 36(11):1493-6. PubMed ID: 517534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of inadvertent microbial contamination of dextrose solutions.
    Mendie UE; Hugbo PG; Nasipuri RN
    West Afr J Med; 1996; 15(4):190-5. PubMed ID: 9020594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between length of time and contamination in open intravenous solutions.
    Amonsen S; Gren JE
    Nurs Res; 1978; 27(6):372-4. PubMed ID: 251249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.
    Reiter PD; Robles J; Dowell EB
    Ann Pharmacother; 2004 Oct; 38(10):1603-7. PubMed ID: 15328398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-chemical stability and sterility of previously prepared saline infusion solutions for use in out-of-hospital emergencies.
    Péculo Carrasco JA; Cosano Prieto I; Gómez Escorza J; Avecilla Sánchez JL; Casal Sánchez Mdel M; Rodríguez Bouza M
    Resuscitation; 2004 Aug; 62(2):199-207. PubMed ID: 15294406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a device for monitoring sterility of injectable fluids.
    Mayhall CG; Pierpaoli PG; Hall GO; Thomas RB
    Am J Hosp Pharm; 1981 Aug; 38(8):1148-50. PubMed ID: 6791498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between intravenous infusate colonisation and fluid container hang time.
    Rickard CM; Vannapraseuth B; McGrail MR; Keene LJ; Rambaldo S; Smith CA; Ray-Barruel G
    J Clin Nurs; 2009 Nov; 18(21):3022-8. PubMed ID: 19821874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors influencing the contents of particles in the infusion solutions in the hospital].
    Han ZF
    Zhonghua Hu Li Za Zhi; 1993 Apr; 28(4):195-8. PubMed ID: 8339365
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical assessment of amygdalin (Laetrile) products.
    Davignon JP; Trissel LA; Kleinman LM
    Cancer Treat Rep; 1978 Jan; 62(1):99-104. PubMed ID: 627001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining a time frame for sterility testing of intravenous admixtures.
    DeChant RL; Furtado D; Smith FM; Godwin HN; Domann DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1305-8. PubMed ID: 6751079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Control of Compounded Crystalloid Fluids for Intravenous Delivery to Horses.
    Magnusson CB; Poulsen KP; Budde JA; Hartmann FA; Aulik NA; Raabis SM; Moreira ASD; Darien BJ; Peek SF
    J Vet Intern Med; 2018 Jan; 32(1):469-473. PubMed ID: 29114956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.